SCHEMBL452389

SCHEMBL452389

COc1ccc(COC(=O)N(COc2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)c(F)c6)CC5)c(F)c4)c3cc2OC)C2CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 4/20 0.55
FLT1 P17948 3/20 0.55
MET P08581 10/20 0.53
AXL P30530 9/20 0.53
KDR P35968 7/20 0.53
FLT3 P36888 3/20 0.53
KIT P10721 3/20 0.53
MERTK Q12866 3/20 0.53
RET P07949 2/20 0.53
AURKA O14965 1/20 0.53
RIPK2 O43353 1/20 0.53
ABCB11 O95342 1/20 0.53
ABL1 P00519 1/20 0.53
EGFR P00533 1/20 0.53
ERBB2 P04626 1/20 0.53
NTRK1 P04629 1/20 0.53
LCK P06239 1/20 0.53
PGR P06401 1/20 0.53
LYN P07948 1/20 0.53
CHRM2 P08172 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL469355 0.84 AURKB (0.57) AURKBFLT1METAXLKDR
SCHEMBL452388 0.84 PDGFRA (0.50) AURKBFLT1METAXLKDR
SCHEMBL469349 0.81 AURKB (0.65) AURKBFLT1METAXLKDR
SCHEMBL469356 0.80 AURKB (0.60) AURKBFLT1METAXLKDR
SCHEMBL469348 0.80 AURKB (0.59) AURKBFLT1METAXLKDR
SCHEMBL469354 0.79 AURKB (0.58) AURKBFLT1METAXLKDR
SCHEMBL5048227 0.78 MET (0.57) AURKBFLT1METAXLKDR
SCHEMBL453312 0.78 AXL (0.49) METAXLKDR
SCHEMBL469262 0.78 AURKB (0.56) AURKBFLT1METAXLKDR
SCHEMBL453854 0.76 KDR (0.46) METAXLKDRPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621904-A2 COMPOUNDS AS C-MET KINASE INHIBITORS Advenchen Laboratories, LLC (US) 2013-08-07 EP disclosed
WO-2012034055-A2 COMPOUNDS AS C-MET KINASE INHIBITORS ADVENCHEN LABORATORIES, LLC (US) 2012-03-15 WO disclosed